Tag Archives: Emerging Markets
By Michael Christel | Published: April 4, 2014
In our second Q&A installment previewing next month’s iPharma2014 conference in New York City, we spoke with David Stern, executive VP of global commercial operations with OvaScience. Stern will be presenting on “Going Global – Innovative Tactics to Engage Emerging Markets and Extend the Global Strategy to a Regional Level.” Drawing from his time as […]
By Julian Upton | Published: February 26, 2014
Bioscience research in China is set to overtake the United States within the next five to ten years, according to data from search engine CiteAb.
By Pharm Exec | Published: February 13, 2014
Accenture has launched the latest version of its annual study of the biopharmaceutical industry. The High Performance Business (HPB) report analyses the long-term performance of the 16 largest pharma companies globally, highlighting industry trends, pharmaceutical business performance analysis, and potential implications for the industry.
By Ben Comer | Published: January 17, 2014
Presenters at the 32nd annual J.P. Morgan Healthcare Conference talked up value-based pricing, emerging market strategies, complex generics and new technology, from bedside devices and genetic sequencers to first-in-class mechanisms of action. Company executives honed in on their chosen therapeutic areas and made the case for aggressive spending in R&D to bring the next generation […]
By Clark Herman | Published: August 7, 2013
Roche this week has announced a partnership with the UN-backed Medicines Patent Pool (MPP) to provide its drug valganciclovir, better known in the developed world as Valcyte, in 138 countries for a reduced price. In addition to making the drug available in these markets for up to 90% cheaper than current price, Roche has decided […]